Effect of Baduanjin Exercise on Metabolic Syndrome Patients

Last updated: December 12, 2023
Sponsor: Cairo University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Metabolic Syndrome

Diabetes Prevention

High Cholesterol (Hyperlipidemia)

Treatment

Baduanjin exercise

Clinical Study ID

NCT06179810
P. T. REC/012/004558
  • Ages 60-75
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Pre/posttest randomized control trial design.

In this study all patients will be randomly assigned into two groups (30 in each group) :

  • Group A will do baduanjin exercise in addition to traditional medical treatment.

  • Group B will take traditional medical treatment only.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • metabolic syndrome patients

Exclusion

Exclusion Criteria:

  • patients with Respiratory diseases
  • patients with pacemaker patients
  • patients with Neurological diseases
  • patients with orthopedic diseases

Study Design

Total Participants: 60
Treatment Group(s): 1
Primary Treatment: Baduanjin exercise
Phase:
Study Start date:
May 15, 2023
Estimated Completion Date:
December 15, 2023

Connect with a study center

  • Ahmed Mohamed Abdelrahman Eldeeb

    Cairo, Qaliop Elbalad
    Egypt

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.